Revance Therapeutics Newsroom

Revance Therapeutics Analyst Ratings

BenzingaDec 23 20:44

Barclays Maintains Equal-Weight on Revance Therapeutics, Lowers Price Target to $3

BenzingaDec 23 20:44

Analysts Offer Insights on Healthcare Companies: Revance Therapeutics (RVNC) and Neurocrine (NBIX)

TipRanksDec 23 09:23

Revance Therapeutics Is Maintained at Neutral by Mizuho

Dow JonesDec 10 21:20

Revance Therapeutics Analyst Ratings

BenzingaDec 10 21:11

Analysts Conflicted on These Healthcare Names: Revance Therapeutics (RVNC), Syndax Pharmaceuticals (SNDX) and Align Tech (ALGN)

TipRanksDec 10 14:34

Mizuho Securities Maintains Revance Therapeutics(RVNC.US) With Hold Rating, Announces Target Price $6.66

Futu NewsDec 10 14:32

Needham Maintains Revance Therapeutics(RVNC.US) With Hold Rating

Futu NewsDec 10 01:31

Analysts' Opinions Are Mixed on These Healthcare Stocks: Artivion (AORT) and Revance Therapeutics (RVNC)

TipRanksDec 10 00:52

Barclays Maintains Revance Therapeutics(RVNC.US) With Hold Rating, Maintains Target Price $7

Futu NewsNov 18 17:32

Barclays Remains a Hold on Revance Therapeutics (RVNC)

TipRanksNov 18 17:12

Mizuho Securities Maintains Revance Therapeutics(RVNC.US) With Hold Rating

Futu NewsNov 13 16:31

Cautious Hold Rating on Revance Therapeutics Amid Ongoing Merger Uncertainties With Crown Laboratories

TipRanksNov 13 16:02

Stifel Maintains Revance Therapeutics(RVNC.US) With Hold Rating, Maintains Target Price $6.66

Futu NewsNov 11 21:37

Revance Therapeutics Analyst Ratings

BenzingaNov 9 00:36

H.C. Wainwright Maintains Revance Therapeutics(RVNC.US) With Hold Rating, Maintains Target Price $6.6

Futu NewsNov 8 23:31

Needham Maintains Revance Therapeutics(RVNC.US) With Hold Rating

Futu NewsNov 8 22:38

Needham Maintains Revance Therapeutics(RVNC.US) With Hold Rating

Futu NewsOct 28 23:32

Mizuho Securities Maintains Revance Therapeutics(RVNC.US) With Hold Rating

Futu NewsOct 17 23:31

Revance Therapeutics (RVNC) Gets a Hold From Mizuho Securities

TipRanksOct 17 23:22